To investigate whether BNIP3 level is correlated with cellular cisplatin cytotoxicity, we knocked down BNIP3 expression in relatively platinum‐sensitive ovarian cancer cell lines to determine whether any concurrent cisplatin sensitivity variation occurs. The gene discussed is BNIP3; the disease is ovarian cancer.